Paper36970507
Podoplanin: A potential therapeutic target for thrombotic diseases.
Huang Y and 5 others. Front Neurol, 2023. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Podoplanin: A potential therapeutic target for thrombotic diseases. Papers, record 36970507. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36970507
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References101
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30522766 | Activation of fibroblastic reticular cells in kidney lymph node during crescentic glomerulonephritis. | Kidney Int | 2019 | https://conductscience.org/library/papers/30522766 | PubMed |
| 2 | 32048302 | Platelet regulates neuroinflammation and restores blood-brain barrier integrity in a mouse model of traumatic brain injury. | J Neurochem | 2020 | https://conductscience.org/library/papers/32048302 | PubMed |
| 3 | 9327748 | Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. | Am J Pathol | 1997 | https://conductscience.org/library/papers/9327748 | PubMed |
| 4 | 33548843 | Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis. | Thromb Res | 2021 | https://conductscience.org/library/papers/33548843 | PubMed |
| 5 | 29676036 | Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism. | J Thromb Haemost | 2018 | https://conductscience.org/library/papers/29676036 | PubMed |
| 6 | 32208352 | Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma. | Transl Oncol | 2020 | https://conductscience.org/library/papers/32208352 | PubMed |
| 7 | 34568969 | Role of podoplanin and Kupffer cells in liver injury after ischemia-reperfusion in mice. | Surg Today | 2022 | https://conductscience.org/library/papers/34568969 | PubMed |
| 8 | 34163489 | CLEC-2 Prevents Accumulation and Retention of Inflammatory Macrophages During Murine Peritonitis. | Front Immunol | 2021 | https://conductscience.org/library/papers/34163489 | PubMed |
| 9 | 17222411 | Functional glycosylation of human podoplanin: glycan structure of platelet aggregation-inducing factor. | FEBS Lett | 2007 | https://conductscience.org/library/papers/17222411 | PubMed |
| 10 | 31778548 | Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin. | Blood | 2019 | https://conductscience.org/library/papers/31778548 | PubMed |
| 11 | 17944973 | Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2. | Cancer Sci | 2008 | https://conductscience.org/library/papers/17944973 | PubMed |
| 12 | 23548777 | Effects of everolimus on oxidative stress in kidney model of ischemia/reperfusion injury. | Am J Nephrol | 2013 | https://conductscience.org/library/papers/23548777 | PubMed |
| 13 | 15515019 | Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. | Int J Cancer | 2005 | https://conductscience.org/library/papers/15515019 | PubMed |
| 14 | 9744646 | Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. | Shock | 1998 | https://conductscience.org/library/papers/9744646 | PubMed |
| 15 | 30580704 | Prognostic Significance of Plasma CLEC-2 (C-Type Lectin-Like Receptor 2) in Patients With Acute Ischemic Stroke. | Stroke | 2019 | https://conductscience.org/library/papers/30580704 | PubMed |
| 16 | 34608736 | Podoplanin promotes tumor growth, platelet aggregation, and venous thrombosis in murine models of ovarian cancer. | J Thromb Haemost | 2022 | https://conductscience.org/library/papers/34608736 | PubMed |
| 17 | 32441651 | Podoplanin promotes cancer-associated thrombosis and contributes to the unfavorable overall survival in an ectopic xenograft mouse model of oral cancer. | Biomed J | 2020 | https://conductscience.org/library/papers/32441651 | PubMed |
| 18 | 25458834 | A platform of C-type lectin-like receptor CLEC-2 for binding O-glycosylated podoplanin and nonglycosylated rhodocytin. | Structure | 2014 | https://conductscience.org/library/papers/25458834 | PubMed |
| 19 | 26031780 | Nutrition and Atherosclerosis. | Arch Med Res | 2015 | https://conductscience.org/library/papers/26031780 | PubMed |
| 20 | 31391335 | High-dimensional analysis reveals a pathogenic role of inflammatory monocytes in experimental diffuse alveolar hemorrhage. | JCI Insight | 2019 | https://conductscience.org/library/papers/31391335 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42583349 | Podoplanin-positive extracellular vesicles in ovarian cancer: linking thrombosis, platelet crosstalk, and cancer stemness - a narrative review. | Ann Med Surg (Lond) | 2026 | https://conductscience.org/library/papers/42583349 | PubMed |
| 41835213 | Emerging roles of haemostatic proteins as markers of disease progression and prognosis in breast cancer. | Explor Target Antitumor Ther | 2026 | https://conductscience.org/library/papers/41835213 | PubMed |
| 41465476 | Does Podoplanin (PDPN) Reflect the Involvement of the Immunological System in Coronary Artery Disease Risk? A Single-Center Prospective Analysis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465476 | PubMed |
| 40809467 | Mechanisms of Cancer Cell Lymphatic Endothelialization in Tumor Lymphangiogenesis and Metastasis: A Comprehensive Review. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/40809467 | PubMed |
| 38391918 | Interaction between NSCLC Cells, CD8+ T-Cells and Immune Checkpoint Inhibitors Potentiates Coagulation and Promotes Metabolic Remodeling-New Cues on CAT-VTE. | Cells | 2024 | https://conductscience.org/library/papers/38391918 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36970507
GET https://conductscience.org/api/papers/v1/36970507/references?page=2